Term
|
Definition
|
|
Term
|
Definition
Osmitrol
Osmotic Diuretic |
|
|
Term
|
Definition
Lasix
20-80 mg/day BID
Loop Diuretic |
|
|
Term
|
Definition
|
|
Term
|
Definition
12.5-25 mg/day QD
THZ diuretic |
|
|
Term
|
Definition
Lozol
1.25-2.5 mg/day
THZ diuretic |
|
|
Term
Chlorthalidone
Metolazone |
|
Definition
Metolazone = Zaroxyln
THZ diuretic |
|
|
Term
1 -Spironolactone
2- Eplerenone |
|
Definition
1- Aldactone
25-50 mg/day
2- Inspra
Aldosterone Antagonist
(K+ Sparing) |
|
|
Term
|
Definition
1st - ACE w/ diuretic (loop usually)
2nd- Beta blocker
can add:
- ARB
OR
- Aldosterone Antagonst
|
|
|
Term
1- Amiloride
2- Triamterine |
|
Definition
1 - Midamor
2- Dyrenium
50-100 mg/day
Na+ Channel Inhibitor
(K+ Sparing) |
|
|
Term
|
Definition
HYPOkalemia (K)
HYPOmagnesemia (Mg)
HYPERcalcemia (Ca)
HYPERglycemia
HYPERlipidemia
HYPERuricemia --> gout
Orthostatic Hypotension
Less common:
Sexual dysfxn
gynomastia (ald. antagonists)
hypersensitivity
photosensitivity
nephtotoxicity
rash/sulfonamide cross-allergy (THZ, Loop) |
|
|
Term
Diuretic Warning : Renal Disease |
|
Definition
CrCl < 30 = loop
CrCl >30 = THZ
CrCl > 50 = K+ Sparing |
|
|
Term
Diuretic: Drug interactions |
|
Definition
1 - K+ Sparing + KCl supplements
2- ACE and ARB
3 - Digoxin
4- Lithium
5- Bile Acid Resins |
|
|
Term
|
Definition
1 ) flushing, dizziness, nausea, h/a
2) EDEMA and Na RETENTION (use diuretic)
3) TACHYCARDIA (use BB)
4) ANGINA
5) LUPUS |
|
|
Term
|
Definition
activates K+ channels
leads to outflow of K+
leads to less Ca+ in cell (less contraction) |
|
|
Term
|
Definition
1) Dizziness, nausea, H/a,
2) tachycardia
3) edema and Na+ retention
4) angina
5) Hirutism (topical helps with hair baldness) |
|
|
Term
|
Definition
IV Only
degrades into nitric oxide that goes directly to smooth muscle cells
nitric oxide converts GTP --> cGMP
cGMP relaxes smooth muscle |
|
|
Term
Sodium Nitroprusside
Side Effects |
|
Definition
DOES NOT CAUSE ANGINA
1) excessive vasodilation/hypotension
2) cyanide intoxication
(if have liver dysfxn) |
|
|
Term
Non DHP CCB
MOA and Side Effects |
|
Definition
(Verapamil, Diltazem)
blocks type L Ca+ channels
1) decreases HR (bradycardia)
2) constipation = verapamil
3) nausea, GERD, H/a, dizziness, flushing (less than DHP)
|
|
|
Term
|
Definition
Calan SR
Isoptin SR
Verlan
Covera HS (ER)
80-480 mg/day
NON DHP CCB |
|
|
Term
|
Definition
Cardizem SR/CD/LA (ER)
Dilacor XR
Tiazac
Cartia XR
180-360 mg/day
NON DHP CCB |
|
|
Term
|
Definition
more potent than Non-DHP
REFLEX TACHYCARDIA
edema
less likely to cause GI upset, nausea, GERD, Etc |
|
|
Term
|
Definition
do not use IR
Adelat CC
ProcardiaXL
30-90 mg/day
DHP CCB |
|
|
Term
|
Definition
Norvasc
2.5-10 mg/day
DHP CCB |
|
|
Term
|
Definition
BETA BLOCKER
w/ non-dhp (add on to negative inotropic effects)
preexisting cardiac conduction problems
DHP w/ migrane
GI obstrutction
norvasc - liver
diltazem - kidney
verapamil and nifefipine - kidney and liver |
|
|
Term
|
Definition
3A4 = verapmil, diltiazem, nifedepine
erythromycin
digoxin
grapefruit juice
ginseng/ginkgo |
|
|
Term
|
Definition
1) DECREASE GFR
2) INCREASE Na+ reabsorption in proximal and loop
(Direct)
3) INCREASE Na+ reabsorption in late distal/collecting
(Indirect) |
|
|
Term
|
Definition
Zestril
Prinvil
5-40 mg/day |
|
|
Term
|
Definition
Vasotec
2.5-20 mg/day
(half of lisinopril) |
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
Altace
1.25-20 mg day
(1/4 of quinapril) |
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
ACE inhibitor: Bradykinin |
|
Definition
REDUCES degradation of bradykinin
(increase in bradykinin = vasodilation) |
|
|
Term
|
Definition
1) Dry Cough
2) Hypotension/dizziness
3) HYPERkalemia (K+)
4) Fetal defects
5) Elevated ScR
(d/c if >35%)
LESS COMMON:
6) nephrotoxicity
7) Rash (captopril > enalapril)
8) Angiodema (increased vascular perm>
9) neutropenia
10) hepatoxicity |
|
|
Term
|
Definition
risk - hyperkalemia
avoid - dehydration, hypotension
avoid - angiodema
d/c - ScR > 35%
elderly on diuretic, renal dz, CHF- start low dose
DO NOT GIVE IF PREGNANT
|
|
|
Term
|
Definition
1) lithium
2) K+ Sparing Diuretics (hyperkalemia)
3) NSAIDs
4)Loop/THZ diuretics |
|
|
Term
|
Definition
Cozaar
25-100 mg QD or BID |
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
Atacand
8-32 mg QD or BID |
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
1) do NOT effect bradykinin (no cough)
2) inhibit actions of ATII derived from ACE AND other pathways
3) inhibit actions of ATII on AT1 receptors only
(ACE inhibitors may also inhibit some actions of ATII on AT2 receptors) |
|
|
Term
|
Definition
NO COUGH
1) hypotension/dizziness
2) hyperkalemia
3) Fetal Defects
4) headache
5) Fatigue
Rare:
- neutropenia
-nephrotoxicity
-Angiodema |
|
|
Term
|
Definition
-Angiodema
-DO NOT USE IF PREGNANT
hypotension/dehydrated
hepatic/renal failure
hyperkalemic
severe heart failure
renal artery stenosis
|
|
|
Term
|
Definition
K+ Sparing
KCl supplements
2C9/3A4 = losartan
Micardis w/ Digoxin
NSAIDS
|
|
|
Term
|
Definition
competes with Norepinephrine to bind to alpha-1 receptor
decrease peripheral resistance
increase vasodilation (arteries/veins) |
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
alpha-1 antagonist
side effect |
|
Definition
1) orthostatic hypotension
**most likely will faint when given 1st dose so advise to give at bedtime**
2) CNS Sedation
3) Edema
* combo with BB and diuretic will help
4) Sexual dysfxn and priapism
Can be used to help BPH
does NOT cause tachycardia |
|
|
Term
|
Definition
Toprol XL
Lopressor
50-200 mg QD (BID for lopressor) |
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
NON SELECTIVE b1/b2
Inderal
160-480 mg BID |
|
|
Term
|
Definition
NON SELECTIVE b1/b2
Corgard
40-240 mg QD |
|
|
Term
|
Definition
alpha-1/ beta
Normodyne
Trandate
200-800 mg BID |
|
|
Term
|
Definition
alpha-1/ beta
12.5-50 mg BID |
|
|
Term
|
Definition
ISA (partial agonist)
Visken
less likely to cause bradycardia |
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
lungs
liver
pancreas (think about insulin/glucose)
arteriole smooth muscle
|
|
|
Term
|
Definition
1) Dizziness/Orthostasis
2) Bronchospasm
**avoid in asthma/COPD patients**
3) Bradycardia ( HR <60)
4) Dyslipidemia
**although - Can DECREASE dyslipidema with B-1 selective or ISA**
**can avoid changes with alpha/beta **
5) Hyperglycemia
less common:
- sexual dysfx
-fatigue
-cold extremities
-weight gain
- AV conduction abnormalities
-Heart Failure
(esp high doses with LVD patient)
|
|
|
Term
|
Definition
TAPER OVER 14 DAY PERIOD
do not abruptly d/c (upregulation)
Asthma/COPD
cardiac conduction abnormalities
PAD
Dyslipidemia
non-selective > selective
Kidney Imparment
(atenolol, nadolol)
1st pass metabolism (Liver) with propranolol and metoprolol
uncontrolled DM
|
|
|
Term
Guanethidine
MOA and Side effects |
|
Definition
half life = 5 days
blocks release of Norepinephrine
DOES NOT CROSS BBB
Side effects: due to blockade of PERIPHERAL synapses
1) Postural hypotension
2) Diarrhea
3) Delayed ejaculation
|
|
|
Term
Reserpine
MOA and Side Effects |
|
Definition
half life = 1-2 day
blocks norepinephrine storage in secretory vessels
CROSSES THE BBB
Side effects: due to blockade of CENTRAL synapses
1) Sedation
2) Depression
3) parkinsons like symptoms
decrases sympathetic/increases parasympathetic so....
nasal stuffiness
bradycardia
increases gastric acid secretion
diarrhea |
|
|
Term
alpha-2 agonists
MOA and Side effects |
|
Definition
Clonidine (need to taper down if d/c)
Methyldopa (pregnancy 1st line tx)
Guanfacine
ACTIVATES ALPHA-2 RECEPTOR IN BRAIN TO DECREASE NOREPINEPHRINE EXCRETION
Side effects:
1) Anticholinergic : dry mouth, GI disturbances, sedation, fatigue, dizziness
2) depression
rare hepatic dysfxn, lupus (m-dopa) |
|
|
Term
|
Definition
Tekturna (new)
MOA: selectivly binds to renin to block angiotensinogen --> AT I
side effects:
1) cough
2) edema
3) hyperkalemia
|
|
|
Term
|
Definition
> 180/120
WITHOUT target organ injury
goal: reduce to stage 1
over period of hours -days
reevaluate w/i 7 days (usually 1-3)
do not be overly aggressive |
|
|
Term
|
Definition
> 180/120
WITH acute/progressing target organ injury
- encephalopathy
-intracranial hemmorage
-acute LVD w/ pulmonary edema
-dissecting aortic anuerism
-unstable angina
-eclampsia / HTN during pregnancy
Goal: mean arterial pressure drop of 25%
sodium nitroprusside is likely used here |
|
|
Term
|
Definition
inhibits Na/K/2Cl symporter on lumen side
(ascending loop of henle)
lack of K+ decreases potential so Mg and Ca stay there and do not get reabsorbed into blood
*leads to lack of Ca and Mg in blood*
cannot make concentrated urine |
|
|
Term
|
Definition
inhibit Na/Cl symport on lumen side
(early distal tubule)
decreases Na+ in cell with increase Ca/Na antiporter
* leads to increased Ca in blood *
(this can help kidney stones)
hypokalemic alkalosis =b/c of increase of excreted K+ and H+
Uric acid retention --> leads to Gout
|
|
|
Term
|
Definition
37.5/25 = maxzide 25
75/50 = dyazide or maxzide |
|
|
Term
K+ Sparing
MOA/Side effecgt |
|
Definition
blocks aldosterone
or blocks Na+ Channels
hyperkalemia
acidosis
gynomastia
impotence
menstrual irregularites
|
|
|
Term
|
Definition
1st - Beta blocker
(non dhp ccb if can't use)
2nd- ACE/ARB
can add on
- Aldosterone antagonist |
|
|
Term
|
Definition
1st - ACE/ARB
can add on
- diuretic
-BB, CCB |
|
|
Term
|
Definition
1st- ACE/ARB
can add on
- diuretic
-BB, CCB
CrCl <30 = loop
CrCl > 30 = THZ
CrCl > 50 = K+ Sparing |
|
|
Term
Recurrent Stroke Prevention |
|
Definition
1st - ACE w/ diuretic (usually THZ)
OR
ARB |
|
|
Term
|
Definition
1st - BB
(non DHP CCB if can't use)
2nd - ACE/ARB
can add on
-CCB, diuretic (THZ) |
|
|